This page provides access to APT's recent press releases, media coverage and events.
Please click on the headlines for more information.
PRESS RELEASES
SEPTEMBER 30, 2007 APT Pharmaceuticals Secures $32 Million in Series B Financing
DECEMBER 3, 2007 APT Pharmaceuticals Adds Paul Sekhri to Board of Directors
NOVEMBER 19, 2007 APT Pharmaceuticals Expands Management Team
OCTOBER 4, 2007 APT Pharmaceuticals Closes New $22 Million Funding Round
JUNE 5, 2007 APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
SEPTEMBER 6, 2006 Former Chiron Executive Joins APT Pharmaceuticals as CEO
MARCH 21, 2006 APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 Million First Round
MEDIA COVERAGE
